Brown Advisory’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.98M Sell
3,780
-489
-11% -$257K ﹤0.01% 661
2025
Q1
$2.71M Sell
4,269
-247
-5% -$157K ﹤0.01% 595
2024
Q4
$3.22M Sell
4,516
-109
-2% -$77.6K ﹤0.01% 569
2024
Q3
$4.86M Sell
4,625
-37
-0.8% -$38.9K 0.01% 511
2024
Q2
$4.9M Buy
4,662
+13
+0.3% +$13.7K 0.01% 501
2024
Q1
$4.47M Buy
4,649
+639
+16% +$615K 0.01% 509
2023
Q4
$3.52M Sell
4,010
-69
-2% -$60.6K 0.01% 536
2023
Q3
$3.36M Sell
4,079
-1
-0% -$823 0.01% 529
2023
Q2
$2.93M Sell
4,080
-233
-5% -$167K ﹤0.01% 545
2023
Q1
$3.54M Sell
4,313
-251
-5% -$206K 0.01% 519
2022
Q4
$3.29M Sell
4,564
-73
-2% -$52.7K 0.01% 533
2022
Q3
$3.2M Buy
4,637
+1,675
+57% +$1.15M 0.01% 508
2022
Q2
$1.75M Buy
2,962
+383
+15% +$226K ﹤0.01% 590
2022
Q1
$1.8M Sell
2,579
-26
-1% -$18.2K ﹤0.01% 600
2021
Q4
$1.65M Buy
2,605
+198
+8% +$125K ﹤0.01% 631
2021
Q3
$1.46M Buy
2,407
+3
+0.1% +$1.82K ﹤0.01% 630
2021
Q2
$1.34M Buy
2,404
+114
+5% +$63.7K ﹤0.01% 639
2021
Q1
$1.08M Buy
2,290
+9
+0.4% +$4.26K ﹤0.01% 687
2020
Q4
$1.1M Sell
2,281
-450
-16% -$217K ﹤0.01% 634
2020
Q3
$1.53M Buy
2,731
+4
+0.1% +$2.24K ﹤0.01% 544
2020
Q2
$1.7M Buy
2,727
+34
+1% +$21.2K ﹤0.01% 523
2020
Q1
$1.31M Buy
2,693
+20
+0.7% +$9.76K ﹤0.01% 529
2019
Q4
$1M Buy
2,673
+127
+5% +$47.7K ﹤0.01% 634
2019
Q3
$707K Buy
2,546
+1,246
+96% +$346K ﹤0.01% 683
2019
Q2
$407K Sell
1,300
-790
-38% -$247K ﹤0.01% 803
2019
Q1
$859K Buy
2,090
+168
+9% +$69K ﹤0.01% 837
2018
Q4
$717K Sell
1,922
-1,238
-39% -$462K ﹤0.01% 835
2018
Q3
$1.28M Sell
3,160
-8,663
-73% -$3.5M ﹤0.01% 747
2018
Q2
$4.08M Buy
11,823
+8,898
+304% +$3.07M 0.01% 479
2018
Q1
$1.01M Buy
2,925
+90
+3% +$31K ﹤0.01% 648
2017
Q4
$1.07M Buy
2,835
+110
+4% +$41.3K ﹤0.01% 658
2017
Q3
$1.22M Sell
2,725
-21
-0.8% -$9.39K ﹤0.01% 617
2017
Q2
$1.35M Sell
2,746
-146
-5% -$71.7K ﹤0.01% 611
2017
Q1
$1.12M Buy
2,892
+252
+10% +$97.7K ﹤0.01% 617
2016
Q4
$969K Buy
2,640
+678
+35% +$249K ﹤0.01% 638
2016
Q3
$788K Sell
1,962
-1,540
-44% -$619K ﹤0.01% 660
2016
Q2
$1.22M Buy
3,502
+1,651
+89% +$577K ﹤0.01% 566
2016
Q1
$667K Sell
1,851
-69
-4% -$24.9K ﹤0.01% 653
2015
Q4
$1.04M Buy
1,920
+58
+3% +$31.5K ﹤0.01% 564
2015
Q3
$866K Buy
1,862
+1,132
+155% +$526K ﹤0.01% 588
2015
Q2
$372K Sell
730
-1,340
-65% -$683K ﹤0.01% 694
2015
Q1
$935K Sell
2,070
-169
-8% -$76.3K ﹤0.01% 564
2014
Q4
$919K Sell
2,239
-799
-26% -$328K ﹤0.01% 569
2014
Q3
$1.1M Buy
3,038
+104
+4% +$37.5K ﹤0.01% 532
2014
Q2
$830K Buy
2,934
+35
+1% +$9.9K ﹤0.01% 587
2014
Q1
$871K Buy
2,899
+16
+0.6% +$4.81K ﹤0.01% 556
2013
Q4
$794K Buy
2,883
+350
+14% +$96.4K ﹤0.01% 554
2013
Q3
$793K Buy
+2,533
New +$793K ﹤0.01% 543